NARI 📈 Inari Medical - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45332Y1091

NARI: Thrombectomy Devices, Catheters, Aspiration Systems

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Web URL: https://www.inarimedical.com

Additional Sources for NARI Stock

NARI Stock Overview

Market Cap in USD 3,322m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Equipment
IPO / Inception 2020-05-22

NARI Stock Ratings

Growth 5y -12.1%
Fundamental -25.0%
Dividend -
Rel. Strength Industry -331
Analysts 4.2/5
Fair Price Momentum 52.56 USD
Fair Price DCF 0.61 USD

NARI Dividends

No Dividends Paid

NARI Growth Ratios

Growth Correlation 3m 93%
Growth Correlation 12m -19.2%
Growth Correlation 5y -64.9%
CAGR 5y 5.95%
CAGR/Mean DD 5y 0.15
Sharpe Ratio 12m -0.16
Alpha -47.32
Beta 1.27
Volatility 50.26%
Current Volume 2100.5k
Average Volume 20d 1170.3k
What is the price of NARI stocks?
As of December 21, 2024, the stock is trading at USD 55.45 with a total of 2,100,473 shares traded.
Over the past week, the price has changed by -0.25%, over one month by +13.16%, over three months by +26.95% and over the past year by -11.87%.
Is Inari Medical a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Inari Medical is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -24.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NARI as of December 2024 is 52.56. This means that NARI is currently overvalued and has a potential downside of -5.21%.
Is NARI a buy, sell or hold?
Inari Medical has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy NARI.
  • Strong Buy: 8
  • Buy: 2
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NARI stock price target?
According to ValueRays Forecast Model, NARI Inari Medical will be worth about 58.9 in December 2025. The stock is currently trading at 55.45. This means that the stock has a potential upside of +6.22%.
Issuer Forecast Upside
Wallstreet Target Price 64.4 16.1%
Analysts Target Price 83.1 49.9%
ValueRay Target Price 58.9 6.2%